Skip to main navigation Skip to search Skip to main content

Tarunveer Singh Ahluwalia

  • Phone+45 20558294
20082026

Research activity per year

Personal profile

Research areas

Computational Molecular Biomarker (Prognostic/Diagnostic/Predictive) Discovery in Cardiometabolic Disorders & their treatment (with Precision Medicine Vision) 

1. Mapping molecular risk markers & disease pathways within:

  • Diabetes and its Complications: Diabetic Kidney Disease; Diabetic Foot and Neuropathic Complications; Diabetic Heart Disease 
  • Cross-talk between Diabetes Complications 
  • Other metabolic disorders (Obesity & Neuro-psychiatric traits)

2. Mapping Drug Effect/Response Biomarkers & Pathways  

3. Real World Data (electronic patient register) based clinical risk prediction studies

4. Employing Genetics & Molecular Epidemiology, Bioinformatics & Data Science/AI methods  

Main research areas

1. Diabetic Kidney Disease Genetics Project - READ-GEN (2019-25)  

2. Diabetic Foot Complications Precision Medicine Project - DIALECT (2023-27): Diabetes Lower-Extremity Complications European Research & Training Network.

3. Diabetic Foot & Neuropathy Biomarker (Risk Genes & Proteins) discovery 

4. Investigating Treatment Effects of a drug for Diabetic Cardiovascular Autonomic Neuropathy - FibroCAN Trial (2024-27)

Current research

Projects as PI:

1. Diabetic Kidney Disease Genetics Project - READ-GEN (2019-25) : Re-evaluating the EGFR-Albuminuria relationship in individuals with and without type 2 Diabetes, using GENetics.  Funding: Novo Nordisk Foundation 

2. Diabetic Foot Complications Precision Medicine Project - DIALECT (2023-27): Diabetes Lower-Extremity Complications European Research & Training Network.

Funding: EU Horizon; Role: 1 PhD Study - Risk Prediciton Algorithm Development; Website: https://dialect-diabeticfoot.eu/

3. Diabetic Foot & Neuropathy Biomarker mapping in collaboration with Joslin-BIDMC, Boston, USA

MAP D-Foot (2023-25): Mapping Molecular biomarkers of Diabetic Foot & Neuropathy Complications. Funding: Novo Nordisk Foundation, Steno - N. American Visiting Fellowship

Project as Co-PI

4. Mapping Treatment Effects of a drug for Diabetic Cardiovascular Autonomic Neuropathy - FibroCAN Trial (2024-27):  Mineralocorticoid receptor antagonist treatment for diabetic cardiovascular autonomic neuropathy: a double-blind, randomized placebo-controlled trial

Potential conflicts of interest

None

External positions

Visiting Researcher, Beth Israel Deaconess Medical Center

1 Jul 202430 Jun 2025

Associate Professor, Roskilde University

1 Aug 2022 → …

Associate Professor (Bioinformatics), University of Copenhagen

1 Aug 2020 → …

Post doc, Steno Diabetes Center A/S

1 Jan 201531 Dec 2016

Genomics Consultant, Steno Diabetes Center A/S

1 Jul 201431 Dec 2014

Postdoctoral Researcher, University of Copenhagen

15 Aug 201130 Jun 2014

Postdoctoral Researcher, Skåne University Hospital

1 Apr 200931 Jul 2011

Fingerprint

Dive into the research topics where Tarunveer Singh Ahluwalia is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or